Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024)

Maravai Lifesciences Holdings has reported Dividends Paid - Common over the past 5 years, most recently at -$78000.0 for Q4 2024.

  • Quarterly results put Dividends Paid - Common at -$78000.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was $494000.0 (down 13.64% YoY), and the annual figure for FY2024 was $494000.0, down 94.86%.
  • Dividends Paid - Common for Q4 2024 was -$78000.0 at Maravai Lifesciences Holdings, down from $572000.0 in the prior quarter.
  • Over the last five years, Dividends Paid - Common for MRVI hit a ceiling of $119.7 million in Q4 2020 and a floor of -$78000.0 in Q4 2024.
  • Median Dividends Paid - Common over the past 5 years was $30.9 million (2022), compared with a mean of $33.1 million.
  • Biggest five-year swings in Dividends Paid - Common: soared 40961.48% in 2021 and later crashed 96.94% in 2023.
  • Maravai Lifesciences Holdings' Dividends Paid - Common stood at $119.7 million in 2020, then dropped by 8.1% to $110.0 million in 2021, then crashed by 71.89% to $30.9 million in 2022, then crashed by 95.78% to $1.3 million in 2023, then crashed by 105.98% to -$78000.0 in 2024.
  • The last three reported values for Dividends Paid - Common were -$78000.0 (Q4 2024), $572000.0 (Q2 2024), and $1.3 million (Q2 2023) per Business Quant data.